The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cardiac Troponin-Global Market Insights and Sales Trends 2024
Synopsis
Cardiac troponins are one of the cardiac biomarkers or diagnostic markers centralized to myocardial infarction or heart muscle cell death diagnosis.
The global Cardiac Troponin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cardiac Troponin in various end use industries. The expanding demands from the Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure and Others, are propelling Cardiac Troponin market. Laboratory Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Point-of-care Testing segment is estimated at % CAGR for the next seven-year period.
Troponin is found in skeletal muscle and cardiac muscle of human body, thus increased level of the cardiac troponin circulating in the blood represents the susceptibility of myocardial infarction.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiac Troponin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiac Troponin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiac Troponin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiac Troponin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiac Troponin covered in this report include Abbott Diagnostics, Roche, bioMrieux, BG Medicine, Ortho Clinical Diagnostics, Singulex, Alere, Siemens Healthcare Diagnostics and Beckman Coulter, etc.
The global Cardiac Troponin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Roche
bioMrieux
BG Medicine
Ortho Clinical Diagnostics
Singulex
Alere
Siemens Healthcare Diagnostics
Beckman Coulter
LifeSign
Global Cardiac Troponin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiac Troponin market, Segment by Type:
Laboratory Testing
Point-of-care Testing
Global Cardiac Troponin market, by Application
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cardiac Troponin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cardiac Troponin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Cardiac troponins are one of the cardiac biomarkers or diagnostic markers centralized to myocardial infarction or heart muscle cell death diagnosis.
The global Cardiac Troponin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cardiac Troponin in various end use industries. The expanding demands from the Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure and Others, are propelling Cardiac Troponin market. Laboratory Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Point-of-care Testing segment is estimated at % CAGR for the next seven-year period.
Troponin is found in skeletal muscle and cardiac muscle of human body, thus increased level of the cardiac troponin circulating in the blood represents the susceptibility of myocardial infarction.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiac Troponin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiac Troponin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiac Troponin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiac Troponin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiac Troponin covered in this report include Abbott Diagnostics, Roche, bioMrieux, BG Medicine, Ortho Clinical Diagnostics, Singulex, Alere, Siemens Healthcare Diagnostics and Beckman Coulter, etc.
The global Cardiac Troponin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Roche
bioMrieux
BG Medicine
Ortho Clinical Diagnostics
Singulex
Alere
Siemens Healthcare Diagnostics
Beckman Coulter
LifeSign
Global Cardiac Troponin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiac Troponin market, Segment by Type:
Laboratory Testing
Point-of-care Testing
Global Cardiac Troponin market, by Application
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cardiac Troponin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cardiac Troponin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Cardiac Troponin Market Overview
1.1 Cardiac Troponin Product Overview
1.2 Cardiac Troponin Market Segment by Type
1.2.1 Laboratory Testing
1.2.2 Point-of-care Testing
1.3 Global Cardiac Troponin Market Size by Type
1.3.1 Global Cardiac Troponin Market Size Overview by Type (2018-2029)
1.3.2 Global Cardiac Troponin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cardiac Troponin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cardiac Troponin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cardiac Troponin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cardiac Troponin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cardiac Troponin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cardiac Troponin Sales Breakdown by Type (2018-2023)
2 Global Cardiac Troponin Market Competition by Company
2.1 Global Top Players by Cardiac Troponin Sales (2018-2023)
2.2 Global Top Players by Cardiac Troponin Revenue (2018-2023)
2.3 Global Top Players by Cardiac Troponin Price (2018-2023)
2.4 Global Top Manufacturers Cardiac Troponin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cardiac Troponin Market Competitive Situation and Trends
2.5.1 Cardiac Troponin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cardiac Troponin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cardiac Troponin as of 2022)
2.7 Date of Key Manufacturers Enter into Cardiac Troponin Market
2.8 Key Manufacturers Cardiac Troponin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cardiac Troponin Status and Outlook by Region
3.1 Global Cardiac Troponin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cardiac Troponin Historic Market Size by Region
3.2.1 Global Cardiac Troponin Sales in Volume by Region (2018-2023)
3.2.2 Global Cardiac Troponin Sales in Value by Region (2018-2023)
3.2.3 Global Cardiac Troponin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cardiac Troponin Forecasted Market Size by Region
3.3.1 Global Cardiac Troponin Sales in Volume by Region (2024-2029)
3.3.2 Global Cardiac Troponin Sales in Value by Region (2024-2029)
3.3.3 Global Cardiac Troponin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cardiac Troponin by Application
4.1 Cardiac Troponin Market Segment by Application
4.1.1 Acute Coronary Syndrome
4.1.2 Myocardial Infarction
4.1.3 Congestive Heart Failure
4.1.4 Others
4.2 Global Cardiac Troponin Market Size by Application
4.2.1 Global Cardiac Troponin Market Size Overview by Application (2018-2029)
4.2.2 Global Cardiac Troponin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cardiac Troponin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cardiac Troponin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cardiac Troponin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cardiac Troponin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cardiac Troponin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cardiac Troponin Sales Breakdown by Application (2018-2023)
5 North America Cardiac Troponin by Country
5.1 North America Cardiac Troponin Historic Market Size by Country
5.1.1 North America Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cardiac Troponin Sales in Volume by Country (2018-2023)
5.1.3 North America Cardiac Troponin Sales in Value by Country (2018-2023)
5.2 North America Cardiac Troponin Forecasted Market Size by Country
5.2.1 North America Cardiac Troponin Sales in Volume by Country (2024-2029)
5.2.2 North America Cardiac Troponin Sales in Value by Country (2024-2029)
6 Europe Cardiac Troponin by Country
6.1 Europe Cardiac Troponin Historic Market Size by Country
6.1.1 Europe Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cardiac Troponin Sales in Volume by Country (2018-2023)
6.1.3 Europe Cardiac Troponin Sales in Value by Country (2018-2023)
6.2 Europe Cardiac Troponin Forecasted Market Size by Country
6.2.1 Europe Cardiac Troponin Sales in Volume by Country (2024-2029)
6.2.2 Europe Cardiac Troponin Sales in Value by Country (2024-2029)
7 Asia-Pacific Cardiac Troponin by Region
7.1 Asia-Pacific Cardiac Troponin Historic Market Size by Region
7.1.1 Asia-Pacific Cardiac Troponin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cardiac Troponin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cardiac Troponin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cardiac Troponin Forecasted Market Size by Region
7.2.1 Asia-Pacific Cardiac Troponin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cardiac Troponin Sales in Value by Region (2024-2029)
8 Latin America Cardiac Troponin by Country
8.1 Latin America Cardiac Troponin Historic Market Size by Country
8.1.1 Latin America Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cardiac Troponin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cardiac Troponin Sales in Value by Country (2018-2023)
8.2 Latin America Cardiac Troponin Forecasted Market Size by Country
8.2.1 Latin America Cardiac Troponin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cardiac Troponin Sales in Value by Country (2024-2029)
9 Middle East and Africa Cardiac Troponin by Country
9.1 Middle East and Africa Cardiac Troponin Historic Market Size by Country
9.1.1 Middle East and Africa Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cardiac Troponin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cardiac Troponin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cardiac Troponin Forecasted Market Size by Country
9.2.1 Middle East and Africa Cardiac Troponin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cardiac Troponin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Diagnostics
10.1.1 Abbott Diagnostics Company Information
10.1.2 Abbott Diagnostics Introduction and Business Overview
10.1.3 Abbott Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Diagnostics Cardiac Troponin Products Offered
10.1.5 Abbott Diagnostics Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Roche Cardiac Troponin Products Offered
10.2.5 Roche Recent Development
10.3 bioMrieux
10.3.1 bioMrieux Company Information
10.3.2 bioMrieux Introduction and Business Overview
10.3.3 bioMrieux Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 bioMrieux Cardiac Troponin Products Offered
10.3.5 bioMrieux Recent Development
10.4 BG Medicine
10.4.1 BG Medicine Company Information
10.4.2 BG Medicine Introduction and Business Overview
10.4.3 BG Medicine Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BG Medicine Cardiac Troponin Products Offered
10.4.5 BG Medicine Recent Development
10.5 Ortho Clinical Diagnostics
10.5.1 Ortho Clinical Diagnostics Company Information
10.5.2 Ortho Clinical Diagnostics Introduction and Business Overview
10.5.3 Ortho Clinical Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ortho Clinical Diagnostics Cardiac Troponin Products Offered
10.5.5 Ortho Clinical Diagnostics Recent Development
10.6 Singulex
10.6.1 Singulex Company Information
10.6.2 Singulex Introduction and Business Overview
10.6.3 Singulex Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Singulex Cardiac Troponin Products Offered
10.6.5 Singulex Recent Development
10.7 Alere
10.7.1 Alere Company Information
10.7.2 Alere Introduction and Business Overview
10.7.3 Alere Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Alere Cardiac Troponin Products Offered
10.7.5 Alere Recent Development
10.8 Siemens Healthcare Diagnostics
10.8.1 Siemens Healthcare Diagnostics Company Information
10.8.2 Siemens Healthcare Diagnostics Introduction and Business Overview
10.8.3 Siemens Healthcare Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Siemens Healthcare Diagnostics Cardiac Troponin Products Offered
10.8.5 Siemens Healthcare Diagnostics Recent Development
10.9 Beckman Coulter
10.9.1 Beckman Coulter Company Information
10.9.2 Beckman Coulter Introduction and Business Overview
10.9.3 Beckman Coulter Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Beckman Coulter Cardiac Troponin Products Offered
10.9.5 Beckman Coulter Recent Development
10.10 LifeSign
10.10.1 LifeSign Company Information
10.10.2 LifeSign Introduction and Business Overview
10.10.3 LifeSign Cardiac Troponin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 LifeSign Cardiac Troponin Products Offered
10.10.5 LifeSign Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cardiac Troponin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cardiac Troponin Industrial Chain Analysis
11.4 Cardiac Troponin Market Dynamics
11.4.1 Cardiac Troponin Industry Trends
11.4.2 Cardiac Troponin Market Drivers
11.4.3 Cardiac Troponin Market Challenges
11.4.4 Cardiac Troponin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cardiac Troponin Distributors
12.3 Cardiac Troponin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
